Across TCGA pan-cancer cohorts, OR51F3P RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of OR51F3P’s most consistent transcriptional readouts.
The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where OR51F3P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OR51F3P is over-expressed in tumor.
HNSC and PRAD are the cancer types where OR51F3P tumor–normal differential expression is most reproducible.